Fund name: Oberland Capital Healthcare III
Amount raised: $1.2 billion
Stage of fundraising: Final close
Final close: October 2022 Predecessor Fund: Oberland Capital Healthcare II
The fund surpasses its predecessor, Oberland Capital Healthcare II, which closed in September 2018 on $800 million. The fund will invest in the healthcare sector in Europe, North America and the Asia-Pacific region, with a focus on innovative therapeutics, diagnostics and medical devices.
Oberland Capital received commitments from a variety of institutional investors, including endowments, foundations, pension plans and sovereign wealth funds.